{"altmetric_id":3237464,"counts":{"readers":{"mendeley":32,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:730754"],"posts_count":1}},"citation":{"abstract":"Therapy with continuous positive airway pressure (CPAP) provides several benefits for patients with heart failure (HF) complicated by obstructive sleep apnea (OSA). However, the effect on the prognosis of such patients remains unknown.","abstract_source":"pubmed","altmetric_jid":"4f6fa4ea3cf058f6100024fa","authors":["Takatoshi Kasai","Koji Narui","Tomotaka Dohi","Naotake Yanagisawa","Sugao Ishiwata","Minoru Ohno","Tetsu Yamaguchi","Shin-ichi Momomura"],"doi":"10.1378\/chest.07-1901","first_seen_on":"2015-02-02T16:02:12+00:00","issns":["0012-3692"],"journal":"CHEST","last_mentioned_on":1226360358,"links":["http:\/\/www.chestjournal.org\/cgi\/pmidlookup?view=long&pmid=18198262"],"pdf_url":"http:\/\/journal.publications.chestnet.org\/data\/Journals\/CHEST\/22068\/690.pdf","pmid":"18198253","publisher":"American College of Chest Physicians","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["pulmonarymedicine"],"title":"Prognosis of Patients With Heart Failure and Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/prognosis-patients-heart-failure-obstructive-sleep-apnea-treated-continuous-positive-airway-pressure-3"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3631265,"mean":4.9266893682253,"rank":816079,"this_scored_higher_than_pct":63,"this_scored_higher_than":2292975,"rank_type":"exact","sample_size":3631265,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":94436,"mean":8.1422005400542,"rank":24659,"this_scored_higher_than_pct":72,"this_scored_higher_than":68686,"rank_type":"exact","sample_size":94436,"percentile":72},"this_journal":{"total_number_of_other_articles":3226,"mean":3.7543782945736,"rank":794,"this_scored_higher_than_pct":55,"this_scored_higher_than":1775,"rank_type":"exact","sample_size":3226,"percentile":55},"similar_age_this_journal_3m":{"total_number_of_other_articles":35,"mean":6.2686470588235,"rank":20,"this_scored_higher_than_pct":42,"this_scored_higher_than":15,"rank_type":"exact","sample_size":35,"percentile":42}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":3,"Student  > Doctoral Student":6,"Researcher":4,"Student  > Ph. D. Student":7,"Student  > Postgraduate":1,"Other":5,"Student  > Master":2,"Lecturer":1,"Lecturer > Senior Lecturer":3},"by_discipline":{"Medicine and Dentistry":29,"Psychology":1,"Nursing and Health Professions":1,"Arts and Humanities":1}}}},"posts":{"wikipedia":[{"title":"Donepezil","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=250984888#altmetric_citation_5","license":"public","citation_ids":[3237464,3237465],"posted_on":"2008-11-10T23:39:18+00:00","summary":"Donepezil, marketed under the trade name Aricept by its developer Eisai and partner Pfizer, and now sold as a generic by multiple suppliers, is a centrally acting reversible acetylcholinesterase inhibitor.","page_url":"http:\/\/en.wikipedia.org\/?curid=730754","wiki_lang":"en","author":{"name":"Arcadian","url":"http:\/\/en.wikipedia.org\/wiki\/User:Arcadian"}}]}}